Benitec Biopharma Inc. (BNTC) Operating cash flow 2019–2026
Benitec Biopharma Inc. (BNTC) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$16.5MFY2026 · since FY2019: $4.8M → -$16.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | -$16.5M | +30.0% |
| FY2025 | -$23.6M | -21.6% |
| FY2024 | -$19.4M | -7.7% |
| FY2023 | -$18.0M | -13.3% |
| FY2022 | -$15.9M | -23.9% |
| FY2021 | -$12.8M | -70.3% |
| FY2020 | -$7.5M | -257.3% |
| FY2019 | $4.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice